Trial Site Detail

 

Drug:	Nilotinib or Imatinib
Trial:	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions:	Gastrointestinal Stromal Tumor
Trial Status:	Completed

 

Ottawa Regional Cancer Center University of Ottawa       Ottawa , ON K1H 8L6 Canada

 

Principal Investigator:	Tim Asmis, MD
Contact:	Caroline Proulx, MD 613-737-7700 ext 70316
Activation Status of this Site:	Closed
Notes about this Site:
Ottawa Regional Cancer Center University of Ottawa Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.